TY - JOUR T1 - Thyroid dysfunction diagnosis from routine laboratory tests based on machine learning JF - medRxiv DO - 10.1101/2021.03.30.21254605 SP - 2021.03.30.21254605 AU - Min Hu AU - Chikashi Asami AU - Hiroshi Iwakura AU - Yasuyo Nakajima AU - Ryousuke Sema AU - Tsuyoshi Kikuchi AU - Tsuyoshi Miyata AU - Koji Sakamaki AU - Takumi Kudo AU - Masanobu Yamada AU - Takashi Akamizu AU - Yasubumi Sakakibara Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/20/2021.03.30.21254605.abstract N2 - Approximately 2.4 million patients in Japan need treatment for thyroid disease, including Graves’ disease and Hashimoto’s disease. However, only 450,000 of them are receiving treatment, and many patients with thyroid dysfunction remain largely overlooked. In this retrospective study, we aimed to screen patients with hyperthyroidism and hypothyroidism who would greatly benefit from prompt medical treatment. We examined routine laboratory finding data and machine learning algorithms to investigate whether such accurate and robust screening is possible to prevent overlooking and misdiagnosing thyroid dysfunction. We succeeded in developing a machine learning method to construct a classification model for detecting hyperthyroidism and hypothyroidism in patients using 11 routine laboratory tests. We collected electronic health records and medical checkup data from four hospitals in Japan. As a result of cross-validation and external evaluation, we achieved a high classification accuracy for the hyperthyroidism and hypothyroidism models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional ethical review boards of the three institutions at which the study was conducted gave their approval (Approval Number of Wakayama Medical University Hospital: 2301, Hidaka Hospital: 257, Gunma University Hospital : HS2018-245)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from Japan Thyroid Association but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Japan Thyroid Association. ER -